Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Santen Oy

Home Clinical Trial Sponsors and OrganizationsSanten Oy

Santen Oy

ACTIVE

Østbanegade 123, København Ø, Hovedstaden, Finlandwww.santen.fiSubsidiary

Part of SANTEN PHARMACEUTICAL CO., LTD.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

41

32 active

Approvals

35

Total approvals

Agencies

4

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

13

31.7%

Phase 3

6

14.6%

Trial Status Distribution

Active, not recruiting

32

78.0%

Completed

9

21.9%

Clinical Trials

Trials sponsored by this organization (41)

A clinical trial on the changes in ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switched from Ganfort¿eye drops to Taptiqom¿ eye drops.

Active, not recruiting

Jan 2021123 participants

Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed.

Active, not recruiting

May 201618 participants

Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed.

Active, not recruiting

Jan 201618 participants

Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed.

Active, not recruiting

Dec 201518 participants

A clinical trial on the changes in ocular signs and symptoms in patientswith ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops to Taptiqom® eye drops.

Active, not recruiting

Apr 2015120 participants

A clinical trial on the changes in ocular signs and symptoms in patientswith ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops to Taptiqom® eye drops.

Active, not recruiting

Feb 2015120 participants

A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension

Jun 201417 participants

Study of how tafluprost is distributed in blood circulation after ocular administration in children who have glaucoma or elevated intraocular pressure. Tolerance to the drug and safety in general will also be assessed.

Active, not recruiting

May 201418 participants

Page 1 of 6

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

2

Approvals

EMA

European Medicines Agency

12

Approvals

SFDA

Saudi Food and Drug Authority

3

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

18

Approvals

Recent Approvals

ROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCION

Tafluprost and Timolol Maleate Eye Drops

CATIOLANZE 50 MICROGRAMOS/ML COLIRIO EN EMULSION

ROCLANDA 50 MICROGRAMOS/ML + 200 MICROGRAMOS/ML COLIRIO EN SOLUCION

Ciclosporin Eye Drops （III）

News

No news articles found

On this page

Overview
Clinical Trials41
Approvals35
News

Back to Organizations